DS
NVO

DRW Securities’s Novo Nordisk NVO Stock Holding History

DRW Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,200
Closed -$361K – 1215
2025
Q1 		$361K Buy
+5,200
New +$429K 0.01% 391
2024
Q4 		– Sell
-7,600
Closed -$905K – 727
2024
Q3 		$905K Buy
+7,600
New +$1.01M 0.03% 298

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

DRW Securities's NVO Position: Q1 2026 in Review

DRW Securities opened a new position in Novo Nordisk (NVO) in Q1 2026: 28,275 shares worth $1.04M. The stake represents 0.01% of the portfolio and ranks #325 among its holdings. This is a return to the name: DRW Securities previously reported a position in NVO as recently as Q3 2025.

DRW Securities first reported a position in NVO in Q3 2015 and has held it in 17 quarters since. The position peaked at $10.3M in Q3 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • DRW Securities held 28,275 shares of Novo Nordisk worth $1.04M as of Q1 2026.
  • Novo Nordisk was a new DRW Securities position in Q1 2026.
  • Novo Nordisk made up 0.01% of DRW Securities's portfolio in Q1 2026, its #325 holding.
  • DRW Securities first reported a position in Novo Nordisk in Q3 2015 and has held it in 17 quarters since.
  • DRW Securities's Novo Nordisk position peaked at $10.3M in Q3 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.